Applied Materials enters September having shed almost 13% in a month, with options traders the most defensive they have been all year — and the Street still sitting well above the current price.
The clearest tension this week is in options. The put/call ratio has climbed to 1.42, within a whisker of its 52-week high of 1.44, and running well above its 20-day average of 1.34. That places the reading nearly 1.4 standard deviations above recent norms — investors are paying meaningfully more for downside protection than they have at almost any point in the past year. The move has accelerated alongside the stock's decline: AMAT closed at $441.85 on September 1, down 3.6% on the day and almost 8% on the week.
The lending market, by contrast, tells a much quieter story. Borrow availability is effectively unlimited — shares available to lend dwarf the shares currently borrowed — and short interest, at 1.5% of the free float, has actually fallen 15% over the past week and 23% over the month. With roughly 12.3 million shares short versus 791 million available to borrow, there is no squeeze setup here. Cost to borrow has roughly doubled over the past week to 0.64%, but that number remains trivially low in absolute terms. Shorts are not crowding in; if anything they have been exiting. This is a holder-led selloff, not a short-driven one.
The Street has not followed the price lower. The analyst consensus mean price target is $640.89, implying roughly 45% upside from current levels — a gap that reflects bullish post-earnings revisions from mid-August balanced against a single trim from Mizuho, which cut its target to $590 from $650 while keeping an Outperform rating. UBS moved the other way: Timothy Arcuri raised his Buy-rated target to $695 on September 1, just the day before this note, making it one of the more pointed recent statements of conviction on the name. The broader post-earnings wave — JP Morgan to $660, Bernstein to $700, TD Cowen reiterating $700 — points to a Street that remains firmly bullish even after AMAT reported a sharp one-day drop of 7.5% on August 13. That reaction, and the subsequent 9.5% five-day drift lower, stands as the most recent marker of how quickly sentiment can turn even when fundamentals hold. The bull case centres on AMAT's dominance in wafer fabrication equipment and a >40% year-on-year revenue growth outlook for CY26; the bear case flags cyclicality, concentration risk, and the integration drag from recent acquisitions.
Sector context reinforces that this week's move is not company-specific. Close peers LRCX and KLAC fell 7.8% and 6.8% respectively, while smaller names UCTT, ONTO, and COHU dropped between 11% and 13%. The weakness is broad-based semiconductor equipment selling. AMAT is actually holding up better than several of its closest correlates on a week-over-week basis — a relative resilience that may partly reflect the recent bullish analyst flow giving some investors reason to hold.
One insider data point worth noting: CFO Brice Hill sold 7,500 shares at $479.25 on August 25 — a $3.6 million open-market sale not filed under a 10b5-1 plan. It is a single transaction rather than a cluster, and discretionary sales by senior insiders at prices well above where the stock trades today carry at least some informational weight. Net insider activity over the past 90 days reflects that sale as the only meaningful open-market transaction.
What to watch next: the November 12 earnings date is the next hard catalyst, and with the PCR this close to its annual high and the analyst consensus this far above spot, the question heading into that print is whether the demand cycle data points are strong enough to pull the stock back toward the $640-$700 range the Street is modelling — or whether sector-wide pressure continues to widen that gap further in the interim.
See the live data behind this article on ORTEX.
Open AMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
